Product
HPV9
1 clinical trial
1 indication
Indication
Cervical Intraepithelial NeoplasiaClinical trial
A Phase 1/2 Randomized, Observer-blinded, Multi-country Study to Evaluate Safety and Immunogenicity of Investigational Adjuvanted Human Papillomavirus Vaccine in Females (16 to 26 Years of Age)Status: Active (not recruiting), Estimated PCD: 2024-03-29